Cargando…
U.S. patient preferences for long‐acting HIV treatment: a discrete choice experiment
INTRODUCTION: Recent advances in long‐acting antiretroviral therapy (LA‐ART) could provide new options for HIV treatment and reduce adherence barriers, if regimens are acceptable to patients. We elicited preferences for key attributes of potential LA‐ART regimens among people with HIV (PWH) in the U...
Autores principales: | Graham, Susan M., Barthold, Douglas, Hauber, Brett, Brah, Aaron T., Saldarriaga, Enrique, Collier, Ann C., Ho, Rodney J. Y., Marconi, Vincent C., Simoni, Jane M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10338996/ https://www.ncbi.nlm.nih.gov/pubmed/37439051 http://dx.doi.org/10.1002/jia2.26099 |
Ejemplares similares
-
The systematic development of attributes and levels for a discrete choice experiment of HIV patient preferences for long-acting antiretroviral therapies in the United States
por: Brah, Aaron T., et al.
Publicado: (2022) -
Improvements to Survey Design from Pilot Testing a Discrete-Choice Experiment of the Preferences of Persons Living with HIV for Long-Acting Antiretroviral Therapies
por: Barthold, Douglas, et al.
Publicado: (2022) -
Preference for daily oral pills over long-acting antiretroviral therapy options among people with HIV
por: Barthold, Douglas, et al.
Publicado: (2023) -
Communicating Test Results from a General Health Check: Preferences from a Discrete Choice Experiment Survey
por: Grauman, Åsa, et al.
Publicado: (2021) -
Patient and physician preferences for anticancer drugs for the treatment of metastatic colorectal cancer: a discrete-choice experiment
por: González, Juan Marcos, et al.
Publicado: (2017)